Helix Resource Hub

Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy

By MD, FACP, FACMG Cassie Hajek, Medical Director at Helix

Recent Press Releases

View All Press Releases

Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

May 28, 2025

Press Releases

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

March 18, 2025

Press Releases

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

March 13, 2025

Recent Videos

View All Videos

Videos

Partner Perspectives with Nebraska Medicine

Genetic Insights Project helps Nebraskans take charge of their health

Videos

Partner Perspectives with MUSC - Update

Revolutionizing Healthcare: In Our DNA SC

Videos

Partner Perspectives with Renown Health - Update

The Healthy Nevada Project - update 2023

Recent Published Research

View All Published Research

1

Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

March 19, 2025

2

Published Research

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

March 19, 2025

3

Published Research

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

March 19, 2025

4

Published Research

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

November 21, 2024

5

Published Research

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Discover How Helix is Changing the World of Healthcare

Resources Hub

The Latest Content From Helix

Recent Blog Posts

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Get in touch

The Latest Content From Helix

Recent Blog Posts

Mental Health Awareness Month: Advancing Empathy and Personalization in Care

MedCity Pivot Podcast: Precision Medicine with the CEO of Helix

Helix awarded "Best Overall Genomics Solution" by MedTech Breakthrough Awards

Advancing Cancer Care: Helix's New DPYD Testing for Safer Chemotherapy

Recent Press Releases

Helix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s Treatments

Helix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and Development

Helix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care Forward

Recent Videos

Partner Perspectives with Nebraska Medicine

Partner Perspectives with MUSC - Update

Partner Perspectives with Renown Health - Update

Recent Published Research

Individuals with PMS2 pathogenic variants are at average risk of cancer before age 60

Scalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptions

Population genomic screening leads to improved lipid management in patients with familial hypercholesterolemia

Underestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetes

A novel method for predicting Lp(a) levels from routine outpatient genomic testing identifies those at risk of cardiovascular disease across a diverse cohort

Recent Whitepapers

Performance and Applications of Helix Exome+®​ Assay

White Paper: Semaglutide and Weight Management

Technical Briefing 6: JN.1

Technical Briefing 5: SARS-CoV-2 Antiviral Treatment Gaps

Performance and Applications of Helix Exome+^® Assay

Performance and Applications of Helix Exome+^® Assay